HeLa-, CHO Cells, and PBMCs
In today's fast-paced environment, it's crucial for many industries to have precise cell counting and viability assessment. These processes are essential for ensuring the success and reliability of various applications, including drug screening, pre-clinical development of therapeutics, and recombinant protein production. That's where our automated cell counting device comes in – CytoDirect is designed to meet the evolving needs of industries that rely on the meticulous analysis of cell populations.
How does CytoDirect perform with cancer cell lines such as HeLa?
The system effectively quantifies concentration and viability, supporting experimental reproducibility.
Can CytoDirect support biomanufacturing workflows involving CHO cells?
CytoDirect provides reliable cell counts and viability data critical for process monitoring.
Is CytoDirect suitable for primary immune cells like PBMCs?
The instrument accurately assesses these cells’ viability and concentration, important for immuno-oncology and cell therapy research.
